The main purpose of this study is to evaluate the long-term safety of pregabalin in adolescent patients who participated in the previous fibromyalgia study (A0081180) and who wish to recieve open-label pregabalin
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
63
Oral capsule 75-450 mg/day
Change From Baseline in Pain Numeric Rating Scale by Week
The weekly pain numeric rating scale (Weekly Pain NRS) consists of an 11-point NRS ranging from 0 (no pain) to 10 (worst possible pain), where higher scores indicate worse pain. Participants chose the number that best described the pain during the last week. Negative change indicates improvement.
Time frame: Baseline, Weeks 3, 8, 16, 24 and Last Visit.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Childrens Hospital Los Angeles
Los Angeles, California, United States
Apex Research Institute
Santa Ana, California, United States
Florida Medical Center & Research
Miami, Florida, United States
Harmony Clinical Research, Incorporated
North Miami Beach, Florida, United States
Rheumatology Associates of Central Florida, PA
Orlando, Florida, United States
Medical Research & Health Education Foundation, Inc.
Columbus, Georgia, United States
Kosair Charities Pediatric Clinical Research Unit
Louisville, Kentucky, United States
Kosair Children's Hospital
Louisville, Kentucky, United States
University of Louisville
Louisville, Kentucky, United States
University Pediatric Rheumatology of Kentucky, LLC
Louisville, Kentucky, United States
...and 16 more locations